Insider · CIK 0001422058

Vallone Carol A

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001422058

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-18	DFTXDefinium Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,086 sh	$35.52	+$38.6K	22,296
2026-09-18	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,086 sh	—	—	0
2026-06-11	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+4,666 sh	—	—	21,210
2026-06-11	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	19,188
2025-06-12	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75.2K sh	—	—	75,187
2024-06-10	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,506
2023-06-21	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+13.7K sh	—	—	16,544
2023-06-21	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	29,205
2022-06-01	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+43.1K sh	—	—	43,104
2022-06-01	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+134K sh	—	—	161,587
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+98.2K sh	—	—	126,041
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+775K sh	—	—	802,516
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+34.4K sh	—	—	62,196
2022-06-01	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+43.1K sh	—	—	43,104
2022-06-01	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+134K sh	—	—	161,587
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+98.2K sh	—	—	126,041
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+775K sh	—	—	802,516
2022-06-01	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+34.4K sh	—	—	62,196
2009-10-30	BEVERLY NATIONAL CORPD Disposition to Issuer	Director	DDisposition to Issuer	−485 sh	—	—	805
2009-06-16	BEVERLY NATIONAL CORPA Award	Director	AAward	+250 sh	—	—	485

Recent filings

Accepted (ET)
Sep 184
Vallone Carol A0001193125-26-395892
SEC(opens sec.gov)
Jun 154
Vallone Carol A0001193125-26-271160
SEC(opens sec.gov)
Jun 164
Vallone Carol A0000950170-25-086766
SEC(opens sec.gov)
Jun 124
Vallone Carol A0000950170-24-072473
SEC(opens sec.gov)
Jun 234
Vallone Carol A0000899243-23-016419
SEC(opens sec.gov)
Jun 64/A
Vallone Carol A0001209191-22-034501
SEC(opens sec.gov)
Jun 34
Vallone Carol A0001209191-22-034419
SEC(opens sec.gov)
Nov 24
Vallone Carol A0001181431-09-049459
SEC(opens sec.gov)
Jun 174
Vallone Carol A0001181431-09-031248
SEC(opens sec.gov)

Companies

Address

C/O DEFINIUM THERAPEUTICS, INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007